An 'atlas' of the brain spurs discovery of new cells that could provide map for stroke, Alzheimer's treatments
  Leo Pharma picks Christophe Bourdon as CEO after one-year stint at failed Danish meme stock Orphazyme
  Gamida Cell readies stem cell transplant therapy for FDA submission but seeks strategic partners amid staffing cuts
  Madrigal's NASH prospect clears first phase 3 test, raising hopes it can magic up positive pivotal efficacy data
  Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
  UPDATE: Kaleido confirms layoffs, halts planned phase 2 and appears to have ended COVID-19 program
  Charles River Labs deals with SAMDI Tech to boost discovery business
  Yet another delay at Amryt as EMA calls in experts to inform review of rare disease drug